Department of Military Affairs Tender by Indian Army (14846a898)

Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered

Goods
Qty:79.3K

Tender Timeline

Tender Issue
May 13, 2025 at 3:20 PM

Tender Title: ISOFLURANE BOTTLE OF 250 ML

Reference Number: 14846a898

Issuing Authority

This tender is issued by the Department of Military Affairs, under the Ministry of Defence.

Scope of Work and Objectives

The objective of this tender is to procure isoflurane bottles of 250 ml. The total quantity required for this procurement is 79,349 units. The successful bidder will be responsible for delivering the specified items as per the outlined specifications. This procurement aims to ensure the availability of essential medical resources for military use, enhancing operational efficiency and healthcare provisions within the defense landscape.

Eligibility Criteria

Bidders are required to meet several eligibility criteria to participate in this tender process. Eligible bidders must be registered entities and should have a proven track record in the supply of pharmaceutical products, particularly anesthetic agents and related formulations. Compliance with regulatory standards relevant to pharmaceuticals is a must.

Technical Requirements

Bidders must demonstrate the technical competence to supply isoflurane as per the required specifications. The product should be compliant with pharmacopoeial standards, ensuring potency, quality, and safety. Detailed technical documentation must accompany the initial proposal, manufacturing standards, and quality assurance protocols.

Financial Requirements

Financial stability is critical for bidders. Submission of financial statements for the past three years will be necessary, showcasing the entity’s ability to manage large-scale procurements effectively. Additionally, bidders must disclose their pricing structure, ensuring it is competitive and considerate of the healthcare budget constraints.

Document Submission Details

All documentation pertaining to this tender must be submitted electronically through the designated platform. Proposals should include the eligibility documents, technical specifications, and financial details. Bidders are encouraged to ensure clarity and completeness of their submissions to circumvent any disqualifications due to insufficient information.

Special Provisions

Micro, Small, and Medium Enterprises (MSEs) and startups may receive advantages during the evaluation process. There are provisions that offer allowances to ensure these entities can compete fairly against larger organizations, promoting a diverse and inclusive tendering environment.

Evaluation Process

The evaluation process will be thorough, focusing on the technical compliance, financial offerings, and the capability to deliver the required products. The process will ensure fair competition, with each submission assessed against the set criteria to select the most suitable bidder.

Delivery Locations

Successful bidders will be required to deliver the isoflurane bottles to specified military healthcare facilities across the region, as determined by the Department of Military Affairs. Timely delivery will be crucial in this tender.

Contact Information

For further inquiries regarding this tender, bidders may refer to the authoritative contact channels provided in the tender data. It is advisable to utilize these channels for clarity on proposal specifics or any administrative queries.

In conclusion, this tender for isoflurane bottles of 250 ml presents an opportunity for qualified medical suppliers to partner with the Department of Military Affairs. Bidders with experience in the pharmaceutical sector and a commitment to quality are encouraged to apply to support the health initiatives of our military forces.


Tender BOQ Items

11 Items
1.

Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray

Qty:1330
Unit:1330
30
2.

isoflurane bottle of 250 ml

Qty:900
Unit:900
30
3.

RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm

Qty:150
Unit:150
30
4.

Pegylated GCSF 6 mg Inj

Qty:360
Unit:360
30
5.

HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN

Qty:5900
Unit:5900
30
6.

HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN

Qty:7600
Unit:7600
30
7.

NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE

Qty:60000
Unit:60000
30
8.

Menotrophin 5U FSH 75 ULH Inj

Qty:3000
Unit:3000
30
9.

USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML

Qty:12
Unit:12
30
10.

Inj Posaconazole 300 mg

Qty:72
Unit:72
30
11.

THIOTEPA 15 MG INJ

Qty:25
Unit:25
30

General Information

Item Category
Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray , isoflurane bottle of 250 ml , RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm , Pegylated GCSF 6 mg Inj , HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN , HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN , NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE , Menotrophin 5U FSH 75 ULH Inj , USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML , Inj Posaconazole 300 mg , THIOTEPA 15 MG INJ
Ministry Name
Organisation Name
City

Financial Information

Bid Offer Validity
180 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Inspection Required
No

Tender Documents

4 Documents
GeM-Bidding-7833368.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Chlorohexidine Disinfectant Mouth Wash Bott Of 500 ml,Clobetasol 0.05 percent and Gentamycin 0.1per

GEM
Goods
Qty:11.2L
4 Files
Indian Army
Boq › Boql
Chlorohexidine Disinfectant Mouth Wash Bott Of 500 ml , Clobetasol 0.05 percent and Gentamycin 0.1percent and Miconazole 2 percent oint , Clobetasole Propionate 0.05 percent and Saliclic Acid 3.5 percent Oint , Cyclosporine A micro emulsion 25 mg Tab , Darbepoietin 40 Mcg inj , Desloratidine10mg Tab , Dextrose Monohydrate for oral use pkt of 100 gm Pulv , Deflazacort 30mg Tab , Diltiazem 30 mg Tab , Donepzil 10mg Tab , Duloxetin 30 mg Tab , Disposable cervical Collar , Disposable Syringe 2ml , Disposable Syringe 5 ml , Divalprox sodium 250mg Tab , Divalprox Sodium CR 500MG Tab , Dutasteride 0.5mg Tab , Erythropoitein 10000IU EPO Inj , Eplerenon 50mg Tab , Etodoloc ER 400mg Tab , Ezetimbe 10 mg , Erythropoitein 5000IU Inj , Ethamsylate 250 mg Tab , Etoricoxib 60mg Tab , FAROPENEM 300 mg TAB , Finofibrate 200 mg Tab , Finofibrate 160 tab , Framycetin Sulphate Cream BP 1 percent cream of 20 gm Oint , FuSidic Acid 2 percent Oint 5 gm Tube , Flunarizine 5 mg Tab , Formetrol 20mcg and Budesonide 0.5 mg respusles , Frusemide 40 mg Tab , Gabapentin 300 and methylcobala 500mg tab , Glyceryl Trinitrate CR 2.6 Mg Tab , Heparin Thrombophob Oint 15gm or 20gm tube , Inj Human Insulin Analogue Glargine Inj, 100 IU per ml Recombinant DNA origin 300IU Disposable Pen with 5 needles per pen , Isabgol Husk 3.5gm Pulv , L ORNITHIN L ASPARTATE 150 mg and pancreatin 100 mg Hepamerz Tab , Luliconazole 0.1 percent Oint 30gm , Levosalbutamol 100 mcg and Beclomethasone 100 mcg Inhaler , Levetiracetam 250mg Tab , Levo Salbutamol 1 mg per 5ml bottle of 100 ml Syp , Levodopa 100mg and Carbidopa 10mg Tab , Clindamycin and Adaphelene Oint , Colchicine 0.5 mg Tab , Dexamethasone 4mg Tab , Diclofenac sod 50mg and pcm325mg and Chlorzoxazone 500mg Tab , Desevenalaflaxacin 50 mg , Dextrose 25 percent Inj , Donepzil 5 mg and Memantin10 mg Tab , Drotaverine Inj 40mg amp og 2ml , Donepezil 05 mg Tab , Doxepine 75 mg Cap , Entacavir 0.5mg Tab , Eplerenone 25mg Tab , Exmestene 25 mg Tab , Febuxostat 40 mg Tab , Fluoxetine 20mg Cap , Fluticasone 0.5 percent W V oint tube of 10 gm Oint , Fluvoxamine 100 mg Tab , Gefitinib 250mg Tab , Glibenclamide 5mg Tab , Glipizide 5 Mg Tab , Haloperidol 5 MG Tab , Hydrochlorthiazide 12.5 mg Tab , Hydroxy urea 500 mg Tab , Hydrochlorothiazide 25 mg Tab , Hydrogen Peroxide Solution 500ml , Imipramine 25mg Tab , Imatinib 100mg Tab , Levosulpride 25 mg Tab
May 9, 2025
May 30, 2025 at 7:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity capable of supplying pharmaceutical products, compliance with regulatory standards, and demonstrating a successful history in similar deliveries. It is essential for bidders to provide documentation proving their capabilities, including certifications and proof of past deliveries.

Bidders must adhere to specified technical specifications that ensure the isoflurane meets pharmacopoeial quality standards. The product must demonstrate efficacy, safety, and regulatory compliance, supported by proper documentation such as quality assurance certifications.

While participating in this tender, an Earnest Money Deposit (EMD) may be required to secure the bid. Bidders should check the specific tender requirements for details on the deposit amount and acceptable forms. The EMD acts as a security measure, reinforcing commitment to fulfill the contract upon winning the bid.

The evaluation and selection process will be transparent, focusing on the submitted documents’ technical and financial aspects. Bidders will be rated based on their compliance with the tender requirements, pricing, and overall capability to deliver the requested products within the required timeframe.

Yes, there are specific provisions that favor MSEs and startups during the evaluation process. These entities may receive advantages that allow them to compete effectively, encouraging opportunities for smaller businesses to engage in significant contracts and build their capabilities within the defense sector.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders